Ildong Pharmaceutical (249420.KS) Earnings Analysis
Ildong Pharmaceutical (249420.KS) has no confirmed upcoming earnings date. Trailing P/E 12.32.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 249420.KS next report earnings?
No confirmed upcoming earnings date is currently scheduled for 249420.KS. This page updates as the calendar is published.
249420.KS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-01-27 | 229.67 KRW | n/a | n/a | n/a |
| 2025-06-30 | -107.59355 KRW | n/a | n/a | n/a |
| 2025-05-12 | 36.79 KRW | n/a | n/a | n/a |
| 2025-02-03 | 268.31 KRW | n/a | n/a | n/a |
| 2024-07-31 | -115.96488 KRW | n/a | n/a | n/a |
249420.KS valuation and analyst view
| Trailing P/E | 12.32 |
|---|---|
| Trailing EPS | 1,236.82 KRW |
| Price / book | 1.59 |
| Dividend yield | 1.44% |
| Market cap | 423.78B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Ildong Pharmaceutical (249420.KS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 249420.KS. This page updates as the calendar is published.
Did 249420.KS beat earnings last quarter?
Consensus estimate data was not available for 249420.KS's 2026-01-27 report.
What is 249420.KS's current P/E ratio and EPS?
249420.KS trades at a trailing P/E of 12.32 on trailing EPS of 1236.818120615123 KRW.
What do analysts rate 249420.KS?
249420.KS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.